SRM Announces New Misting Fan Order
JUPITER, FL, April 17, 2024 (GLOBE NEWSWIRE) — SRM Entertainment, Inc., (Nasdaq: SRM) (the “Company” or “SRM”) announced it has […]
Royalty Pharma Declares Second Quarter 2024 Dividend
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved […]
Brera’s Asian And African Football Clubs Back in Action
DUBLIN, Ireland and MILAN, Italy, April 17, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings,” “Brera” or the “Company”) […]
Repligen to Report First Quarter 2024 Financial Results
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first […]
Nature’s Miracle Holding Inc. and Agrify Corporation Agree to Merge
Combined Entity is Expected to Become the Leading Provider of CEA Products and Solution AGRIFY Brings Industry-Leading Cultivation and Extraction […]
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease – – ATH434-201 Phase 2 […]
Gilat to Report First Quarter 2024 Results on May 8th
PETAH TIKVA, Israel, April 17, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader […]
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally. BPL-003 was shown to be […]
La Rosa Reports 91% Year-Over-Year Increase in Revenue to $11.4 Million for the Fourth Quarter of 2023
Acquisition of Six Brokerages Increases the Company’s Gross Profit 207% in Q4 2023 vs Q4 2022 Revenue Increased 21% to […]
Treace to Present at Bank of America Health Care Conference
PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a […]
